Daniel Grosslight
Stock Analyst at Citigroup
(0)
# 4414
Out of 5,240 analysts
128
Total ratings
26.92%
Success rate
-12.08%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cardinal Health | Maintains: Neutral | 120 129 | 123.98 | 4.05% | 5 | Jan 10, 2025 | |
Evolent Health | Maintains: Buy | 21 18 | 11.26 | 59.86% | 4 | Jan 10, 2025 | |
GoodRx Holdings | Maintains: Buy | 7 7 | 4.13 | 51.33% | 7 | Jan 10, 2025 | |
Health Catalyst | Maintains: Buy | 11 10 | 5.88 | 70.07% | 8 | Jan 10, 2025 | |
McKesson | Maintains: Buy | 713 677 | 594.02 | 13.97% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 13 | 14.96 | -16.44% | 9 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 31 35 | 26.1 | 34.1% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 2 3 | 2.75 | -18.18% | 4 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 24 25 | 26.19 | -4.54% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 14.74 | 25.51% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 20.99 | 19.1% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 10 | 3.38 | 178.11% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 | n/a | n/a | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 19 | 9.35 | 103.21% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 10 | 9.3 | 7.53% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 8 | 11.18 | -28.44% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 195 | n/a | n/a | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 3.64 | -65.66% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 2 | n/a | n/a | 1 | Sep 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 18 | n/a | n/a | 2 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 125 38 | n/a | n/a | 1 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | 2.83 | 23.67% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 37 | n/a | n/a | 4 | Dec 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 125 170 | n/a | n/a | 2 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 26 | 28.55 | -8.93% | 6 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 10.35 | 25.6% | 1 | Dec 11, 2019 |